Attovia Therapeutics, Inc. Common Stock (ATTO) trades at $14.73 per share. Technical indicators currently signal "Sell".
Technical & fundamental data as of Nov 16, 2026.
Open?$15.01
High?$15.31
Low?$14.26
Prev. Close?$15.13
Volume?171.5K
Avg. Volume?N/A
VWAP?$14.81
Bid / Ask
Bid?$12.42 × 100
Ask?$17.03 × 100
Spread?$4.61
Midpoint?$14.73
Valuation & Ratios
Market Cap?691.6M
Shares Out?N/A
Float?25.9M
Float %?60.1%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.